Health Care
Coronavirus
President Trump’s Coronavirus Diagnosis Discussed by Dr. Henry Miller
Dr. Henry Miller joins the Lars Larson Show to talk about President Donald Trump’s coronavirus diagnosis. Miller talks about how the President and his staff handled health safety procedures and ways he could have been exposed to COVID-19. Lars Larson National Podcast · Lars Larson National Podcast 10-02-20
Commentary
Import German drug prices to the United States? Nein, danke
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for ...
Blog
Newsom: If You Like Your Internal-Combustion Engine Car, You Can Keep It
When Barack Obama told the country that under Obamacare “if you like your health care plan, you can keep it,” he was dinged for telling the PolitiFact Lie of the Year. California Gov. Gavin Newsom made a similar promise when he signed last week an executive order that will outlaw ...
Health Care
TheStreet Profiles Dr. Henry Miller on FDA Woes
Ex-FDA Doc: Agency Suffering ‘Unprecedented’ Loss of Trust By Adam Smith Early this year, when the novel coronavirus that was devastating China began to spread to other countries, hope came in the promise of a quick vaccine, one that doctors and scientists bet could be created in just a year and ...
Drug Pricing
Wayne Winegarden Featured in Newsweek Drug Pricing Story
Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the ...
Drug Pricing
NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...
Commentary
Massive coverage losses are greatly exaggerated
Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Commentary
Industry Voices—Surprise! There’s a better fix for surprise bills
Federal health officials are trying to reignite the debate over surprise medical bills. In a report issued earlier this summer, the Department of Health and Human Services urged Congress to do something about surprise bills, saying the practice represents a market failure that cannot be corrected on its own. The ...
Commentary
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Commentary
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
President Trump’s Coronavirus Diagnosis Discussed by Dr. Henry Miller
Dr. Henry Miller joins the Lars Larson Show to talk about President Donald Trump’s coronavirus diagnosis. Miller talks about how the President and his staff handled health safety procedures and ways he could have been exposed to COVID-19. Lars Larson National Podcast · Lars Larson National Podcast 10-02-20
Import German drug prices to the United States? Nein, danke
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for ...
Newsom: If You Like Your Internal-Combustion Engine Car, You Can Keep It
When Barack Obama told the country that under Obamacare “if you like your health care plan, you can keep it,” he was dinged for telling the PolitiFact Lie of the Year. California Gov. Gavin Newsom made a similar promise when he signed last week an executive order that will outlaw ...
TheStreet Profiles Dr. Henry Miller on FDA Woes
Ex-FDA Doc: Agency Suffering ‘Unprecedented’ Loss of Trust By Adam Smith Early this year, when the novel coronavirus that was devastating China began to spread to other countries, hope came in the promise of a quick vaccine, one that doctors and scientists bet could be created in just a year and ...
Wayne Winegarden Featured in Newsweek Drug Pricing Story
Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the ...
NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...
Massive coverage losses are greatly exaggerated
Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Industry Voices—Surprise! There’s a better fix for surprise bills
Federal health officials are trying to reignite the debate over surprise medical bills. In a report issued earlier this summer, the Department of Health and Human Services urged Congress to do something about surprise bills, saying the practice represents a market failure that cannot be corrected on its own. The ...
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
